ClinicalTrials.gov
public full text
Public Domain
Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
Patients at least 18 years of age will be enrolled in the study to assess the efficacy and tolerability of Picato gel in the treatment of molluscum contagiosum. Patients must have an immunocompromised condition due to taking immunosuppressive drugs or having an inherited disease affecting the immune system.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MPOX como imitador clínico de molusco contagioso#1135675
- Immunologic Profile of Chronically Photodamaged Skin#831967
- BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator#891570
- Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department#830220
- Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents#1162975
Record · ID 886939
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive